Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GMDTC for elevated cadmium levels
NCT07057414Phase 2Recruiting
- Sponsor
- Jianersheng Pharmaceutical Technology
- Start
- Jul 2025
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gmdtc in cadmium poisoning, sponsored by Jianersheng Pharmaceutical Technology. Started Jul 2025; status: recruiting.
02
Drugs
gmdtc
03
Conditions
cadmium poisoning
Beyond the preview
Go deeper on NCT07057414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07057414.